Clinical Watch List

Understanding the complexity of fungal sepsis caused by Candida species may seem daunting, but one thing is certain: Appropriate laboratory diagnostics like AST and emerging research can help turn the tide in the fight against fungal sepsis. Read our latest white paper, Defending against the rising threat of drug-resistant fungal sepsis as we explore current challenges, as well as tactical considerations for laboratories and new innovations in the battle against antifungal resistance.

At Bologna University Hospital in Italy, Prof. Federico Pea and his team have developed a comprehensive and interdisciplinary program to tailor antibiotic therapy based on accurate minimum inhibitory concentration (MIC) values, real-time therapeutic drug monitoring (TDM) data, and pharmacokinetic/pharmacodynamic (PK/PD) parameters. Learn more about their approach, which aims to support optimized patient outcomes while helping to prevent the emergence of antibiotic resistance and preserve the future of antibiotics.

In our new infographic, Superbug surcharge: The economics of MDROs and HAIs, we take a closer look at the financial and patient impact of superbugs, and how advancements in screening, detection, and treatment can help healthcare facilities control the consequences of MDROs and HAIs, leading to better patient outcomes.  

Sepsis, the body’s extreme response to infection, remains a significant health concern globally. In the context of MDROs, bacterial agents like E. coli and Klebsiella spp. force difficult decision-making in healthcare settings. For these challenging infections, timely and accurate antimicrobial susceptibility testing (AST) plays a crucial role in determining the right antimicrobials to kill the bacteria or stop it from spreading, thereby helping the body’s natural immune system to fight the infection that causes severe sepsis.

In this white paper, we take a look at the critical role of AST in guiding antibiotic therapy, different methodologies, and best practices to enhance laboratory accuracy and communication.

Every minute counts when MDROs can cause healthcare-associated infections (HAIs) – infections patients acquire during healthcare treatment. These infections can quickly spiral out of control and become costly and deadly emergencies. Labs and clinicians make consequential decisions each and every day as pathogens, such as MRSA, Acinetobacter baumannii and Clostridioides difficile, become more prevalent and present greater risks to patients and hospital operations.

But while clinicians and labs may feel the odds are stacked against them in preventing MDROs and the dangerous and costly HAIs they can cause, there is hope. Let's explore the new tools, techniques, and clinical perspectives that can help even the score.